Concepedia

Stéphane Prost

SP

13

Publications

1.1K

Citations

11

H-Index

1995

Active since

Affiliations

Commissariat à l'Énergie Atomique et aux Énergies Alternatives(Current)

Inserm

Hôpital Saint-Louis

Infectious Disease Models and Innovative Therapies

Université de Versailles Saint-Quentin-en-Yvelines

Stéphane Prost is an author at Commissariat à l'Énergie Atomique et aux Énergies Alternatives specializing in medicine, histocompatibility, and hla immunogenetics.

ORCID

Top concepts

Publications per year

1995–2016

13

Publications

13

Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease

Philippe Rousselot, Aude Charbonnier, Pascale Cony‐Makhoul et al. · Journal of Clinical Oncology · 2013 · 405 citations · Full text

Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists

Stéphane Prost, Francis Relouzat, Marc Spentchian et al. · Nature · 2015 · 256 citations · Full text

, , +6

Soluble HLA-G molecule

Philippe Moreau, Edgardo D. Carosella, M Teyssier et al. · Human Immunology · 1995 · 94 citations

, , +3

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study

Philippe Rousselot, Stéphane Prost, Joëlle Guilhot et al. · Cancer · 2016 · 91 citations · Full text

Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARγ/STAT5 signaling pathway in macaques

Stéphane Prost, Mikael Le Dantec, Sylvie Augé et al. · Journal of Clinical Investigation · 2008 · 62 citations · Full text

Rows per page

1–5 of 13